Vivanza Biosciences Ltd

Pursuant to regulation 32 of SEBI (Listing Obligation and Disclosure Requirements 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December 2019 regarding submission of Statement of Deviation or Variation from proceeds of Public issue/right issue/preferential issue Qualifed Institutions Placement(QIP) etc we hereby confirm that the Company has not raised any further funds by means of Public issue Rights issue or preferential Issue etc. Hence the statement of Deviation(s) or Variation(s) is not being provided as it is not applicable to the Company